BusinessNeuralstem Reports First Quarter 2017 Fiscal Results Provides Clinical and Business UpdateBy Nasdaq OMXMay 10, 2017, 8:07 PM UTC
BusinessNeuralstem Reports First Quarter 2017 Fiscal Results Provides Clinical and Business UpdateBy Nasdaq OMXMay 10, 2017, 8:07 PM UTC
BusinessNeuralstem Announces the Closing of $20 Million Strategic Investment from Tianjin Pharmaceutical Group International Holdings Co., LTD.By Nasdaq OMXDec 12, 2016, 12:38 PM UTC